Document is current
Any future updates will be listed below
-
Authors
Navarro-Muñoz, Jorge C.
Selem-Mojica, Nelly
Mullowney, Michael W. http://orcid.org/0000-0002-2884-4307
Kautsar, Satria A. http://orcid.org/0000-0002-9815-511X
Tryon, James H.
Parkinson, Elizabeth I. http://orcid.org/0000-0002-3665-5522
De Los Santos, Emmanuel L. C. http://orcid.org/0000-0002-9496-9407
Yeong, Marley
Cruz-Morales, Pablo http://orcid.org/0000-0002-6751-8897
Abubucker, Sahar
Roeters, Arne
Lokhorst, Wouter
Fernandez-Guerra, Antonio
Cappelini, Luciana Teresa Dias
Goering, Anthony W.
Thomson, Regan J.
Metcalf, William W. http://orcid.org/0000-0002-0182-0671
Kelleher, Neil L. http://orcid.org/0000-0002-8815-3372
Barona-Gomez, Francisco
Medema, Marnix H. http://orcid.org/0000-0002-2191-2821
-
Funding
Funding for this research was provided by:
Consejo Nacional de Ciencia y Tecnología (postdoctoral scholarship 263661, PhD scholarship 204482, CBS2017_285746, 2017_051TAMU)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (F32GM120999)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F32CA221327)
Graduate School for Experimental Plant Sciences
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (863.15.002)
U.S. Department of Health & Human Services | National Institutes of Health (U01GM110706)
RCUK | Biotechnology and Biological Sciences Research Council (BB/M017982/1)
EC | Horizon 2020 Framework Programme (634486)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R01AT009143)
- License Information
-
More Information
Article History
Received: 3 December 2018
Accepted: 4 October 2019
First Online: 25 November 2019
Competing interests
: M.H.M. is on the scientific advisory board of Hexagon Bio and co-founder of Design Pharmaceuticals. N.L.K., W.W.M. and R.J.T. are on the board of directors of MicroMGx, and A.W.G. is chief scientific officer at MicroMGx.
